Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

AbCellera Biologics Inc. - Common Shares (NQ:ABCL)

7.830 -0.280 (-3.45%)

Streaming Delayed Price Updated: 10:44 AM EDT, Jul 6, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,436,397
Open	8.050
Bid (Size)	7.820 (900)
Ask (Size)	7.830 (800)
Prev. Close	8.110
Today's Range	7.450 - 8.150
52wk Range	2.745 - 8.420
Shares Outstanding	287,686,199
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Today 9:00 EDT

From AbCellera Biologics Inc.

Via Business Wire

Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies

June 17, 2026

From AbCellera Biologics Inc.

Via Business Wire

Performance

YTD	+128.3%	+128.3%
1 Month	+39.3%	+39.3%
3 Month	+131.0%	+131.0%
6 Month	+128.3%	+128.3%
1 Year	+94.3%	+94.3%

More News

AbCellera Appoints Dr. Victor Sandor to its Board of Directors

June 05, 2026

From AbCellera Biologics Inc.

Via Business Wire

AbCellera Biologics Bets on Hot Flash Antibody as Pipeline Pivot Gains Steam ↗

June 04, 2026

Via MarketBeat

AbCellera Biologics Inc (NASDAQ:ABCL) Reports Narrower-Than-Expected Loss on Patent Settlement Windfall ↗

February 24, 2026

Via Chartmill

AbCellera Biologics Q1 Earnings Call Highlights ↗

May 11, 2026

Via MarketBeat

AbCellera (ABCL) Q1 2026 Earnings Transcript ↗

May 11, 2026

Via The Motley Fool

Stay updated with the stocks that are on the move in today's after-hours session. ↗

May 11, 2026

Via Chartmill

AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635

May 11, 2026

From AbCellera Biologics Inc.

Via Business Wire

AbCellera to Present at Upcoming Investor Conferences in May and June 2026

May 07, 2026

From AbCellera Biologics Inc.

Via Business Wire

AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

April 20, 2026

From AbCellera Biologics Inc.

Via Business Wire

AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026

April 01, 2026

From AbCellera Biologics Inc.

Via Business Wire

CRA: Here’s the TFSA Contribution Room for 2026 and Why Now Is the Best Time to Use It ↗

March 26, 2026

Via The Motley Fool

These stocks are moving in today's after hours session ↗

February 24, 2026

Via Chartmill

AbCellera Reports Full Year 2025 Business Results

February 24, 2026

From AbCellera Biologics Inc.

Via Business Wire

The Biotechnology Renaissance: AI and Capital Collide in a Multi-Trillion Dollar Pivot

February 17, 2026

Via MarketMinute

AbCellera to Present at Upcoming Investor Conferences in March and April 2026

February 11, 2026

From AbCellera Biologics Inc.

Via Business Wire

AbCellera to Report Full Year 2025 Financial Results on February 24, 2026

January 22, 2026

From AbCellera Biologics Inc.

Via Business Wire

AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause

January 12, 2026

From AbCellera Biologics Inc.

Via Business Wire

AbCellera and Bruker Reach Global Settlement of Patent Litigation

December 18, 2025

From AbCellera Biologics Inc.

Via Business Wire

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

November 10, 2025

From AbCellera Biologics Inc.

Via Business Wire

AbCellera Biologics Inc (NASDAQ:ABCL) Reports Mixed Q3 2025 Results with Revenue Beat and Wider Loss ↗

November 06, 2025

Via Chartmill

AI Stocks Extend Selloff, Nasdaq 100 Eyes Worst Week Since April: What's Moving Markets Friday? ↗

November 07, 2025

Via Benzinga

AbCellera Reports Q3 2025 Business Results

November 06, 2025

From AbCellera Biologics Inc.

Via Business Wire

AI Stocks Slide Again, Bitcoin Dips Near $100,000: What's Moving Markets Thursday? ↗

November 06, 2025

Via Benzinga

Frequently Asked Questions

Is AbCellera Biologics Inc. - Common Shares publicly traded?

Yes, AbCellera Biologics Inc. - Common Shares is publicly traded.

What exchange does AbCellera Biologics Inc. - Common Shares trade on?

AbCellera Biologics Inc. - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for AbCellera Biologics Inc. - Common Shares?

The ticker symbol for AbCellera Biologics Inc. - Common Shares is ABCL on the Nasdaq Stock Market

What is the current price of AbCellera Biologics Inc. - Common Shares?

The current price of AbCellera Biologics Inc. - Common Shares is 7.830

When was AbCellera Biologics Inc. - Common Shares last traded?

The last trade of AbCellera Biologics Inc. - Common Shares was at 07/06/26 10:44 AM ET

What is the market capitalization of AbCellera Biologics Inc. - Common Shares?

The market capitalization of AbCellera Biologics Inc. - Common Shares is 2.25B

How many shares of AbCellera Biologics Inc. - Common Shares are outstanding?

AbCellera Biologics Inc. - Common Shares has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.